Childhood hepatic fascioliasis treated with triclabendazol [2];Tratamiento con triclabendazol en la fasciolasis hepática infantil

Anales Espanoles de Pediatria

Volumn 57, Issue 2, 2002, Pages 171-172

  Iglesias Escalera, G ^a   Elvira Pardilla, A I ^a   Rodrigo Palacios, J ^a   Merino Arribas, J M ^a   Marrero Calvo, M ^a   Garcia Bravo M ^a   Vegas Alvarez, A M ^b  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^b Centro de Salud San Agustin   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; BITHIONOL; PRAZIQUANTEL; TRICLABENDAZOLE;

CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; FASCIOLA HEPATICA; FASCIOLIASIS; HUMAN; LETTER; MALE; SCHOOL CHILD;

ANTHELMINTICS; BENZIMIDAZOLES; CHILD; FASCIOLIASIS; HUMANS; LIVER DISEASES, PARASITIC; MALE;

EID: 0036704554     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. De Górgolas, Torres R, Verdejo C, et al. Infestación por Fasciola hepatica. Biopatología y nuevos aspectos diagnósticos y terapéuticos. Enf Infecc Microbiol Clin 1992;10:514-9.
2. Almendras M, Rivera J, Seijas J, Almendras K. Hepatic fasciolasis in children, uncommon clinical manifestations. Arq Gastroenterol 1997;34:241-7.
3. Merino J, Amérigo MJ, Alvarez L, Erdozain I. Fasciolasis humana con presentación atípica y grave. Tratamiento con triclabenclazol. Enf Infecc Microbiol Clin 1998;16:28-30.
4. Apt W, Aguilera X, Vega F, Miranda C, Zulanlay I, Perez C, et al. Treatment of human chronic fasciolasis with triclabendazole: Drug efficacy and serologic response. Am J Trop Hyg 1995;52: 532-5.
5. Picot S, Querrec M, Ghez JL, Goullier-Fleuret A, Grillot R, Ambroise-Thomas P. A new report of Triclabendazole efficacy during invading phase fasciolasis. Europ J Clin Microbiol 1992;11:269-70.
6. Bechtel U, Feucht HE, Held E, Vogl T, Nothdurft HD. Infection with fasciola hepatica in a family: Diagnosis and treatment. Dtsch Med Wschr 1992;117:978-82.
7. García ML, Marugán de Miguelsanz JM, Ordóñez MJ Costilla S, Díez N. Fasciolasis hepática: Un nuevo caso en la infancia. An Esp Pediatr 1999;50:65-7.
8. Loutan L, Bouvier M, Rojanawisut B, Stalder H, Rouan MC, Buescher G, et al. Single treatment of invasive fasciolasis with Triclabendazole. Lancet 1989;2:383.
9. Lecaillon JB, Godbillon J, Campestrini J, Naquira C, Miranda L, Pacheco R, et al. Effect of food on the bioavailability of Triclabendazole in patients with fasciolasis. Br J Clin Pharmacol 1998;45:601-4.
10. Laird PP, Boray JC. Human fasciolasis successfully treated with Triclabendazole. Aust N Z J Med 1992;22:45-7.